CoChat

Presymptomatic studies in genetic frontotemporal dementia

Open access
Rohrer, J.D., Warren, J.D., Fox, N.C., Rossor, M.N. · 2013 · Revue Neurologique
Cited by 56

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Approximately 20% of patients with the neurodegenerative disorder frontotemporal dementia (FTD) have an autosomal dominant pattern of inheritance. Genetic FTD is caused by mutations in three genes in most cases (progranulin, microtubule-associated protein tau and chromosome 9 open reading frame 72) although a number of other genes are rare causes. Studies of other neurodegenerative diseases have shown imaging and biomarker evidence of disease onset many years prior to the development of symptoms. Similar studies in genetic FTD are now revealing evidence of a series of presymptomatic changes, initially in plasma biomarkers followed by MR imaging abnormalities of functional and structural connectivity and then grey matter atrophy. Lastly, neuropsychometric tests become abnormal in proximity to the onset of symptoms. Such studies have been relatively small until now but research centres with an expertise in genetic FTD are now forming consortia such as the Genetic Frontotemporal Dementia Initiative (GenFI) to create larger cohorts that can form the basis of future clinical trials. Les démences frontotemporales (DFT), dans environ 20 % des cas, résultent d’un mode de transmission autosomique dominant. Les trois causes génétiques les plus fréquentes sont des mutations des gènes GRN, MAPT et des expansions hexanucléotidiques au sein du gène C9orf72, alors que d’autres gènes sont plus rarement impliqués. Des études dans d’autres maladies neurodégénératives ont montré que des marqueurs biologiques et d’imagerie du début de la maladie précèdent de plusieurs années les premiers symptômes. Des études similaires concernant les formes génétiques des DFT mettent actuellement en évidence des modifications présymptomatiques, initialement des biomarqueurs plasmatiques, suivies des modifications en imagerie de la connectivité fonctionnelle et structurelle puis des signes d’atrophie de la substance grise. Enfin, les performances aux tests neuropsychologiques deviennent anormales dans la période proche du début des symptômes. Ces études restent peu nombreuses mais les centres ayant une expertise dans la génétique des DFT se regroupent actuellement en consortium tel que l’Initiative pour la Génétique des Démences FrontoTemporales (GenFI) afin de disposer de larges cohortes qui serviront de base au développement des futurs essais cliniques.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neurol.2013.07.010

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 56

Metadata

Authors
Rohrer, J. D., Warren, J. D., Fox, N. C., & Rossor, M. N.
Venue
Revue Neurologique
Publisher
Elsevier BV
Published
2013-10
Volume
169
Issue
10
Pages
820-824
ISSN
0035-3787 (ISSN-L)
OpenAlex
W1975394589
Cited by
56
References
8
FWCI
2.76
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Presymptomatic studies in genetic frontotemporal dementia. https://app.cochat.ai/papers/10.1016/j.neurol.2013.07.010
The paper
Rohrer, J. D., Warren, J. D., Fox, N. C., & Rossor, M. N. (2013). Presymptomatic studies in genetic frontotemporal dementia. Revue Neurologique. https://doi.org/10.1016/j.neurol.2013.07.010

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.